The estimated Net Worth of Michael Joseph Plunkett is at least $1.09 Milhão dollars as of 24 August 2017. Michael Plunkett owns over 75,000 units of Alphatec Inc stock worth over $1,090,692 and over the last 11 years Michael sold ATEC stock worth over $0.
Michael has made over 2 trades of the Alphatec Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Michael exercised 75,000 units of ATEC stock worth $408,750 on 24 August 2017.
The largest trade Michael's ever made was exercising 75,000 units of Alphatec Inc stock on 24 August 2017 worth over $408,750. On average, Michael trades about 6,923 units every 57 days since 2014. As of 24 August 2017 Michael still owns at least 200,127 units of Alphatec Inc stock.
You can see the complete history of Michael Plunkett stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD, CA, 92008.
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster, eLlc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Alphatec Inc executives and other stock owners filed with the SEC include: